Taken together, our data suggest that CD39 expression is responsible for CD8 Tregs induced with TGF-β to inhibit lupus nephritis in cGVHD and CD39 is a novel biomarker for the identification of CD8+ Tregs. This evidence concerns the gene ENTPD1 and lupus nephritis.